Ubrelvy

Product manufactured by Allergan, Inc.

Application Nr Approved Date Route Status External Links
NDA211765 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ubrelvy Is Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. Limitations Of Use Ubrelvy Is Not Indicated For The Preventive Treatment Of Migraine. Ubrelvy Is A Calcitonin Gene-Related Peptide Receptor Antagonist Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. ( 1 ) Limitations Of Use Ubrelvy Is Not Indicated For The Preventive Treatment Of Migraine. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ubrogepant UBROGEPANT ZINC95598454

Comments